Spots Global Cancer Trial Database for BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity
Official Title: BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity
Study ID: NCT05051631
Conditions
Study Description
Brief Summary: The central goal of this study is to test strategies to implement evidence-based breast cancer risk assessment in healthcare clinics in Tennessee. The BRAVE Strategy (Breast cancer Risk Assessment - achieVing Equity) study aims to assess the feasibility, reach, acceptability, and appropriateness of select customized strategies to increase uptake of breast cancer risk assessment. The investigators will achieve these aims through a conducting a stepped-wedge trial conducted in 10 healthcare clinics in the state of Tennessee. The primary outcome is the proportion of women age 25-49 having risk assessment. Secondary outcomes include the numbers of 1) women identified as high-risk; 2) pursuing risk-adherent screening; and 3) diagnosed with breast cancer.
Detailed Description:
Eligibility
Minimum Age: 25 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact Details
Name: Lucy B Spalluto, MD MPH
Affiliation: Vanderbilt University Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
